Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avandamet vs Metformin plus Sulphonylurea in Overweight Type 2 Diabetes
NCT00359112Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Feb 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00359112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359112.